{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:22:12Z","timestamp":1785363732276,"version":"3.55.0"},"reference-count":0,"publisher":"Sociedade Portuguesa de Reumatologia","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ARP Rheumatol"],"DOI":"10.63032\/rfpy6607","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:10:27Z","timestamp":1767132627000},"page":"300-304","source":"Crossref","is-referenced-by-count":2,"title":["Tocilizumab in immune checkpoint inhibitor-induced myositis, myocarditis, and myasthenic syndrome: a rare case report and review of the literature"],"prefix":"10.63032","volume":"4","member":"49459","published-online":{"date-parts":[[2025,12,30]]},"container-title":["ARP Rheumatology"],"original-title":[],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:10:28Z","timestamp":1767132628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.arprheumatology.com\/section.php?id=1796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,30]]}},"URL":"https:\/\/doi.org\/10.63032\/rfpy6607","relation":{},"ISSN":["2795-4552"],"issn-type":[{"value":"2795-4552","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]}}}